Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | PAM | P19021 | 2/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | TOP2A | P11388 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1363684 | 0.94 | DGKA (0.61) | DGKADNM1MAPTMAPK1PAM | |
| SCHEMBL1363538 | 0.92 | DGKA (0.64) | DGKADNM1MAPTPAMNAAA | |
| SCHEMBL1364134 | 0.92 | DGKA (0.64) | DGKADNM1MAPTPAMNAAA | |
| SCHEMBL1365041 | 0.92 | DGKA (0.64) | DGKADNM1MAPTPAMNAAA | |
| SCHEMBL1365483 | 0.92 | DGKA (0.64) | DGKADNM1MAPTPAMNAAA | |
| SCHEMBL1365018 | 0.89 | DGKA (0.61) | DGKADNM1MAPTMAPK1PAM | |
| SCHEMBL21811747 | 0.88 | DGKA (0.64) | DGKADNM1MAPTPAMNAAA | |
| SCHEMBL1363981 | 0.86 | — | — | |
| SCHEMBL33810 | 0.86 | DGKA (0.74) | DGKADNM1MAPTMAPK1PAM | |
| SCHEMBL19638 | 0.86 | DGKA (0.67) | DGKADNM1MAPTMAPK1PAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113980117-B | Fenpyroximate antigen and preparation method and application thereof | 西南大学 | 2024-07-12 | — | — | CN | claimed |
| CN-117820460-A | Methoxypiperidine ethyl antigen and preparation method and application thereof | 西南大学 | 2024-04-05 | — | — | CN | claimed |
| CN-114560834-B | Spirodiclofen hapten, antigen and antibody as well as preparation methods and applications thereof | 西南大学 | 2024-02-09 | — | — | CN | claimed |
| CN-114560834-A | Spirodiclofen hapten, antigen and antibody as well as preparation method and application thereof | 西南大学 | 2022-05-31 | — | — | CN | claimed |
| CN-113980117-A | Fenpyroximate antigen and preparation method and application thereof | 西南大学 | 2022-01-28 | — | — | CN | claimed |
| CN-102260362-B | Atactic multiblock styrene polymer and preparation method thereof | UNIV BEIJING CHEMICAL | 2013-04-10 | — | — | CN | claimed |
| CN-102260362-A | Atactic multiblock styrene polymer and preparation method thereof | — | 2011-11-30 | — | — | CN | claimed |
| WO-2025126794-A1 | METHOD FOR PRODUCING POLYCARBOXYLIC ACID ESTER COMPOUND | 本州化学工業株式会社 | 2025-06-19 | — | — | WO | disclosed |
| WO-2025126793-A1 | METHOD FOR PRODUCING POLYCARBOXYLIC ACID ESTER COMPOUND | 本州化学工業株式会社 | 2025-06-19 | — | — | WO | disclosed |
| CN-113980117-B | Fenpyroximate antigen and preparation method and application thereof | 西南大学 | 2024-07-12 | — | — | CN | disclosed |
| US-11958802-B2 | Migration-resistant photopolymerization sensitizer | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2024-04-16 | — | — | US | disclosed |
| CN-117820460-A | Methoxypiperidine ethyl antigen and preparation method and application thereof | 西南大学 | 2024-04-05 | — | — | CN | disclosed |
| CN-114560834-B | Spirodiclofen hapten, antigen and antibody as well as preparation methods and applications thereof | 西南大学 | 2024-02-09 | — | — | CN | disclosed |
| EP-0335586-A1 | Piperidine & piperazine derivatives, process for preparing the same and pharmaceutical compositions containing the same | UBE INDUSTRIES, LTD. (JP) | 1989-10-04 | — | — | EP | disclosed |
| US-4855449-A | Prostacyclin (PGI2) analogues | SHIONOGI & CO., LTD. (JP) | 1989-08-08 | — | — | US | disclosed |
| US-4820836-A | ANTICOAGULANTS, ANTIULCER AGENTS | SHIONOGI & CO., LTD. (JP) | 1989-04-11 | — | — | US | disclosed |
| EP-0240890-A2 | Prostacyclin (PGI2) analogues | SHIONOGI & CO., LTD. (JP) | 1987-10-14 | — | — | EP | disclosed |
| EP-0040793-B1 | NOVEL QUINAZOLINE-DIONE COMPOUNDS, PROCESS FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | Ishikawa, Masayuki (JP) | 1985-08-28 | — | — | EP | disclosed |
| US-4405623-A | HYPOTENSIVE AGENTS, VASODILATORS | MASAYUKI ISHIKAWA (JP) | 1983-09-20 | — | — | US | disclosed |
| EP-0040793-A1 | Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof | Ishikawa, Masayuki (JP) | 1981-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11958802-B2 | Migration-resistant photopolymerization sensitizer | F12, F10, PCNA | DGKA 2032/4885DNM1 4250/4885MAPT 3487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.